Nav: Home

Exercise could work as treatment for prostate cancer

January 05, 2016

A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.

The PANTERA study, led by Sheffield Hallam University, will focus on 50 men who have the disease, but whose cancer has not spread. Half of the men in the study will carry out two-and-a-half hours of aerobic exercise every week for 12 months - initially with the support of a qualified trainer and then with free access to local gyms. The other half will be given information about the benefits of exercise for cancer patients but will have no supervised sessions.*

Prostate cancer that has not spread is sometimes treated with surgery or radiotherapy. But this can have side-effects so many men opt for active surveillance instead, which involves monitoring the disease. All the men in the PANTERA study are and will remain on active surveillance - and they will also be closely monitored as part of the study itself.

If the participants can successfully keep up their exercise regime for 12 months, the study is expected to lead to a full-scale trial to look at the potential benefits of combining active surveillance and exercise for some prostate cancer patients.

This trial - believed to be the first of its kind in the world - would aim to test whether regular exercise can help keep prostate cancer from spreading to other parts of the body and could be a viable NHS treatment.

Study leader Dr Liam Bourke, principal research fellow at Sheffield Hallam University, said: "Evidence suggests that men who are physically active after a prostate cancer diagnosis have better cancer survival than men who aren't active. It's not clear yet how this works, but it might be that exercise affects the way some genes regulate cancer cell growth and DNA repair.

"The clinical academic team in Sheffield have been working hard for eight years to develop the intervention that is being tested in this exciting study. It builds on what we already know and is the first step towards finding out whether exercise could be an effective and practical NHS treatment for localised prostate cancer. If we show it works and is feasible, it could be a real leap forward and good news for cancer patients."

David Curtis (68) from Sheffield was diagnosed with early prostate cancer in March 2014 and has been exercising as part of the PANTERA study for several weeks - and continuing to exercise is one of his New Year resolutions. He said: "I was never someone to go to the gym, even though I've always been active, but now I go to the gym twice a week and do lots of walking. Since starting on the study, I've started to lose weight and my PSA level has come down which is a really positive indicator.

"I feel privileged to be on the study and pleased to be part of any research which might be useful to others."

PSA is produced by both normal and cancerous prostate cells, and a high PSA level in the blood can be a sign of cancer. Study researchers will check what effect regular exercise has on the body, including on PSA levels, and will also gather information about how well the study runs, to prepare for a full-scale trial.

In the UK, prostate cancer is the most common cancer in men with around 43,400 new cases diagnosed each year and around 10,800 deaths. Many types of prostate cancer grow extremely slowly and are not likely to spread, while others are more aggressive.

Professor Malcolm Mason, Cancer Research UK's prostate cancer expert, said: "Taking exercise is good for all of us, whether or not we have cancer - but this interesting study could help discover whether it's particularly helpful and a viable, additional treatment for some prostate cancer patients. Focusing on patients whose disease is under active surveillance, rather than being treated in other ways, provides a fantastic opportunity to monitor the effects of exercise on prostate cancer - and could even shed light on its potential as a supplemental therapy for other types of cancer."

Anyone interested in taking part in the study or finding out more about it, should visit cancerresearchuk.org/pantera.
-end-


Cancer Research UK

Related Prostate Cancer Articles:

ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer.
Patient prostate tissue used to create unique model of prostate cancer biology
For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses.
Moffitt Cancer Center awarded $3.2 million grant to study bone metastasis in prostate cancer
Moffitt researchers David Basanta, Ph.D., and Conor Lynch, Ph.D., have been awarded a U01 grant to investigate prostate cancer metastasis.
New findings concerning hereditary prostate cancer
For the first time ever, researchers have differentiated the risks of developing indolent or aggressive prostate cancer in men with a family history of the disease.
Prostate cancer discovery may make it easier to kill cancer cells
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy.
More Prostate Cancer News and Prostate Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...